C1GALT1 and neoplasm: Immunohistochemical analyses revealed decreased T antigen and C1GALT1 expression and cell proliferation, and enhanced apoptosis, in ITZ-treated and C1GALT1-silenced tumor xenografts (Fig. S4A).